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sion in 3 of 4 studies (1 study p  ! 0.05, but better outcomes 
in one study) and for patients with incident depression in 2 
of 4 studies (no studies p  ! 0.05).  Conclusions: Although it is 
still suggested that ACS patients with first and new-onset 
depression are at particularly increased risk of worse prog-
nosis, the inconsistent results from the studies included in 
this systematic review show that there is no consistent evi-
dence to support such statements. 
 Copyright © 2011 S. Karger AG, Basel 
Introduction
 Depression after acute coronary syndrome (ACS) is 
associated with an increased risk of new cardiovascular 
events or mortality. A meta-analysis including 22 studies 
found that depressed myocardial infarction (MI) patients 
were at 2–2.5 times higher risk of new cardiovascular 
events or mortality than nondepressed MI patients  [1] .
 Recently, research is focusing on different aspects of 
post-ACS depression that may be especially associated 
with cardiovascular prognosis, such as depression sever-
ity (i.e. the distinction between minor and major depres-
sion)  [2] , depressive symptom profile  [3, 4] , persistence of 
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 Abstract 
 Background: Depression after acute coronary syndrome 
(ACS) is associated with worse cardiac outcomes. This sys-
tematic review evaluated whether depressed ACS patients 
are at differential risk depending on the recurrence and tim-
ing of onset of depressive episodes.  Methods: MEDLINE, 
 EMBASE and PsycINFO were searched from inception to 11 
April 2009. Additionally, reference lists and recent tables of 
contents of 34 selected journals were manually searched. 
Eligible studies evaluated cardiovascular outcomes for sub-
groups of ACS patients with depression or depressive symp-
toms according to recurrence or onset.  Results: Six studies 
were included that reported outcomes for subgroups of ACS 
patients with first-ever versus recurrent depression. Four of 
these reported also outcomes for post-ACS onset versus pre-
ACS onset depression, and incident versus nonincident de-
pression. Worse outcomes (odds ratio  1 1.4) were reported 
for ACS patients with first-ever depression in 3 of 6 studies 
(1 study p  ! 0.05), for patients with post-ACS onset depres-
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the depressive episode after the acute event  [5] and treat-
ment resistance  [6] .
 In addition, it has been suggested that the degree to 
which post-ACS depression is associated with cardiovas-
cular prognosis may be related to the nature and timing 
of the depressive episode  [7–11] , including whether the 
depressive episode is first-ever or recurrent, and whether 
its onset is before or after the acute event. It was hypoth-
esized that recurrent depressive episodes are associated 
with worse cardiovascular prognosis than first-ever de-
pressive episodes  [7, 8] , which was plausible because ac-
cumulating exposure to depression may be more harmful 
than first-ever exposure to depression. The first study 
that reported data on patients with first versus recurrent 
depression was published by Lespérance et al.  [7] in 1996. 
In that study, 6 of 15 MI patients with recurrent depres-
sion died by 18 months after MI (40%) compared to 2 of 
20 MI patients with first episodes during their index hos-
pitalization (10%). A study by Grace et al.  [8] almost 10 
years later, on the other hand, found depressed ACS pa-
tients who reported no history of depressed mood to be 
at higher risk of mortality 5 years after the index ACS (31 
of 130, 24%) compared to those reporting a history of de-
pressed mood (15 of 105, 14%). In addition to depression 
recurrence, timing of depression onset (i.e. before or after 
ACS) has been reported to be related to cardiovascular 
outcomes. Worse cardiovascular outcomes were reported 
for patients with post-MI onset or incident (i.e. first-ever 
and with an onset after the MI) depressive episodes com-
pared to patients with pre-MI onset or nonincident epi-
sodes  [9, 10] . Post-ACS onset and in particular incident 
depression may therefore be a distinct subtype of depres-
sion with the unique feature that it may be triggered by 
the acute event. As a result, this subtype may specifically 
be associated with worse cardiovascular prognosis.
 The objective of the present systematic review was to 
evaluate whether subgroups of depressed ACS patients 
are at different risk of subsequent cardiac events or mor-
tality, depending on whether the depressive episode is 
first or recurrent or whether its onset is before or after the 
cardiac event. To this end, 3 subgroup comparisons were 
examined, depending on whether the post-ACS depres-
sive episode (1) was first-ever or recurrent, (2) had an on-
set before or after the cardiac event, or (3) was incident or 
























From the onset of the depressive episode there was no period of feeling better and
normal functioning lasting at least 2 months
A depressive episode that has an onset after the acute event
(i.e. during the acute event the patient was not depressed)
A depressive episode meeting both of the abovementioned criteria
(i.e. first-ever and post-ACS onset)
 Fig. 1. Subgroups of post-ACS depressed 
patients, according to recurrence and on-
set of the depressive episode relative to the 
acute event. 
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 Methods 
 Search Strategy 
 MEDLINE, EMBASE and PsycINFO were systematically 
searched from inception to April 11, 2009. Search strings included 
appropriate MeSH/EMTREE terms and free text words for car-
diovascular disease, depression and possible cardiovascular out-
comes (i.e. ‘mortality’ and ‘event’). In addition, a manual search 
of reference lists from all articles selected for full-text review, rel-
evant reviews and tables of contents of 34 selected journals from 
May 1, 2008, to April 11, 2009, was done. E-mails were sent to au-
thors of included studies, as well as authors of 4 key trials  [12–15] 
on antidepressant treatment in cardiac patients, to query about 
the possible existence of other published or unpublished eligible 
studies. Translators were used to evaluate non-English titles/ab-
stracts and articles as necessary.
 Study Selection 
 From selected abstracts, all prognostic studies or randomized 
controlled trials (RCTs) with data on the relationship between 
post-ACS depression or depressive symptoms and cardiovascular 
outcomes (i.e. mortality, cardiovascular mortality, recurrent car-
diac events) were selected for full-text review. From these, 2 inves-
tigators independently selected papers that were eligible for inclu-
sion. Cohen’s   was calculated to assess chance-corrected agree-
ment. Any disagreements were resolved by consensus.
 Eligible articles included studies in any language (1) that were 
prospective cohort studies or prospective controlled studies (in-
cluding RCTs), (2) that reported data on patients with ACS (MI 
and/or unstable angina), (3) that assessed the presence of post-
ACS depression with a validated clinical interview [for example 
the Composite International Diagnostic Interview (CIDI) or the 
Diagnostic Interview Schedule] or depressive symptoms with an 
established cutoff level on a validated questionnaire [such as the 
Beck Depression Inventory (BDI) or the 9-item Patient Health 
Questionnaire) within 3 months after the index event, (4) that in-
cluded cardiovascular outcomes, defined as all-cause mortality, 
cardiovascular mortality or recurrent cardiac events, that oc-
curred after the assessment of post-ACS depression and were as-
sessed for a period of at least 6 months after the depression assess-
ment, (5) that provided data on outcomes for subgroups of de-
pressed ACS patients with (a) recurrent versus first-ever episodes, 
(b) pre-ACS versus post-ACS onset episodes, and/or (c) incident 
versus nonincident episodes, and (6) that included at least 10 pa-
tients with the cardiovascular outcome of interest.
 Data Extraction and Quality Assessment 
 From the eligible articles, 2 authors independently extracted 
information about study cohorts, depression measurement and 
outcome measures. Any discrepancies were resolved by consen-
sus. In some cases, data on study characteristics were retrieved 
from other articles reporting on the same study sample. Some 
studies reported outcomes for 1 or 2, but not all 3 subgroup com-
parisons. If from the study methods it appeared that data were 
available for the missing subgroup comparison(s), the authors 
were asked to provide additional data on the missing subgroups.
 For each subgroup comparison in each study an unadjusted 
odds ratio (OR) with a 95% confidence interval (CI) was calcu-
lated to reflect the differential risk of the cardiovascular outcome 
based on subgroup definitions. Because some studies may be too 
small to find an increased risk for one subgroup over the other 
that would reach statistical significance, we did not only consider 
a statistically significant increased risk, but also ‘potentially’ in-
creased risk as relevant. Because with binary outcomes the mag-
nitude of an OR varies with the prevalence of the outcome, there 
is no agreed-upon standard for a certain OR to be considered clin-
ically relevant  [16] . We considered substantive differential risk to 
be potentially present between subgroups when OR  1 1.4 or  ! 0.7, 
regardless of statistical significance. Only unadjusted results were 
used, because of the small numbers of patients in each subgroup 
with the outcome  [17–19] and because each study used different 
control variables, which limited the ability to compare multivari-
able results. The following characteristics were extracted as pos-
sible confounders in order to evaluate whether they differed sub-
stantively between subgroups: age, gender, left ventricular ejec-
tion fraction, Killip class, history of MI, score on the BDI at 
baseline, smoking, body mass index, the presence of diabetes and 
use of antidepressants. When these characteristics were not de-
scribed separately for subgroups in the article, the authors were 
asked to provide them. Whether these characteristics differed sig-
nificantly between subgroups was evaluated with an indepen-
dent-sample t test for continuous variables and a   2 test for di-
chotomous variables. Because of the small number of included 
studies, no funnel plot was made to explore possible publication 
bias.
 To assess the quality of the included studies, 2 investigators 
independently rated each study on 11 criteria that were generated 
based on a review by Altman  [20] . It should be noted that the rat-
ings reflect the quality of each study relative to our key questions 
rather than the general quality of the study per se.
 The search strings, the list of relevant reviews and selected 
journals that were used with the literature search, the variables 
that were extracted from the articles and the quality criteria that 
were used can be requested from the corresponding author.
 Results 
 Search Strategy and Selection of Articles 
 The literature search yielded 1,977 unique abstracts. 
Of these, 104 articles were selected for full-text review. An 
additional 11 articles were identified for full-text review 
from manual searching, references of relevant reviews or 
references of articles identified for full-text review. Of 
these, 4 articles were found to be eligible for inclusion  [8, 
9, 21, 22] , and 111 were excluded ( fig. 2 ). Cohen’s   for in-
terrater agreement was 0.88. In addition, our survey of 
study authors led to the identification of 2 more studies 
meeting all eligibility criteria that were therefore includ-
ed as well. The first was an article by Glassman et al.  [23] 
concerning the SADHART (Sertraline Antidepressant 
Heart Attack Randomized Trial) study that was in press 
at the time the searches were conducted. The second 
came from an analysis of data of the MIND-IT (Myocar-
dial Infarction and Depression Intervention Trial) study 
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 [14] , which was presented in a letter to the editor that was 
in press at the time the searches were conducted  [24] .
 Retrieval of Additional Subgroup Information on 
Outcomes and Baseline Characteristics 
 All 6 included studies reported outcomes for patients 
with first versus recurrent depressive episodes. Four of 
these reported also outcomes for patients with pre-ACS 
versus post-ACS onset and incident versus nonincident 
depression. For ENRICHD (Enhancing Recovery in Cor-
onary Heart Disease)  [22] , all information for the sub-
groups on cardiac outcomes and baseline characteristics 
could be derived from the article. For the study of Grace 
et al.  [8] , the authors provided original data on subgroup 
characteristics. For SADHART  [23] outcomes for pa-
tients in all subgroups could be derived from the article, 
an additional article  [25] , and additional data on sub-
group characteristics were provided by the authors. Par-
ker et al.  [21] reported in their article only outcomes for 
patients with incident, nonincident and post-ACS onset 
depression. The authors provided original data to also 
determine outcomes for patients with first, recurrent and 
pre-ACS onset depression, as well as data on baseline 
characteristics for subgroups. De Jonge et al.  [9, 26] re-
ported in the original article outcomes for patients with 
incident versus nonincident depression at 3 or 12 months 
after the MI. In the present systematic review only pa-
tients diagnosed as having depression 3 months after the 
MI were included. Information on outcomes and baseline 
characteristics for subgroups of patients with first, recur-
rent, pre-MI onset, post-MI onset, incident and noninci-
dent depression were retrieved from the original data. In 
this study, the CIDI  [27] was used to assess the presence 
of an ICD-10 post-MI depressive episode. Information 
about whether the onset of the depressive episode was 
before or after the MI was obtained by extending the 
CIDI with additional questions about the presence of 
each of the depressive symptoms in the 4 weeks before 
and the period after the MI. Outcomes were counted only 











– 1,058 no original
data
– 716 no ACS
patients
– 45 no post-ACS
depression






– 2 from manual search
through tables of
contents
– 8 from references from
relevant reviews
– 1 from references of
full-text review articles
111 excluded
– 3 no original data
– 16 no ACS patients
– 16 no post-ACS
depression
– 2 no outcomes
assessed/reported
– 73 no data on
onset or recurrence
of depression
– 0 follow-up period
not long enough









 Fig. 2. Flow diagram of the search. 
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IT, a published letter presented outcomes for patients 
with first versus recurrent depression in a small subgroup 
of the MIND-IT sample that received pharmacological 
treatment for depression  [24] . In the present systematic 
review all randomized MI patients from MIND-IT who 
were diagnosed as having depression 3 months after the 
MI were included. Information on outcomes and charac-
teristics for all subgroups was retrieved from the original 
data. As in the de Jonge study  [9] , information about 
whether the onset of the depressive episode was before or 
after the MI was obtained by extending the CIDI with 
additional questions. Outcomes were counted only if they 
occurred after depression assessment.
 Study Characteristics 
 Study characteristics and the association of different 
subgroups with cardiovascular outcomes for the 6 includ-
ed studies are shown in  table 1 . In some cases, study char-
acteristics were retrieved from additional articles about 
the same sample  [12, 14, 25, 26, 28] . In the study of Par ker 
et al.  [21] , all patients with a first episode had incident 
depression and all patients with nonincident depression 
had a recurrent episode. This resulted in the same risk 
estimates for those 2 subgroup comparisons, which is 
consistent with an overlap of 100% between subgroups. 
Apart from this example, for the 4 studies that presented 
data on multiple subgroup comparisons, the percentage 
of patients with a given classification that were also clas-
sified in another group (e.g. post-ACS onset and incident 
depression) ranged from 41 to 90%.
 Association of Subgroups with Cardiovascular 
Outcomes and Demographical, Medical and 
Behavioral Characteristics 
 Table 2 shows the ORs with 95% CIs for cardiac out-
comes for each of the subgroup comparisons. Supplemen-
tary tables 1, 2 and 3, which can be requested from the 
corresponding author, show for each subgroup data on 
age, sex, LVEF, Killip class, history of MI, BDI score at 
hospitalization or within 30 days after the acute event, 
smoking status, body mass index, the presence of diabe-
tes mellitus and antidepressant use.
 First-Ever versus Recurrent Depressive Episodes 
 All 6 studies reported cardiac outcomes for ACS pa-
tients with first-ever versus recurrent depressive epi-
sodes. In one of these, patients with a first-ever depressive 
episode were found to be at significantly increased risk of 
worse cardiac outcomes (i.e. p  ! 0.05). In 2 of the other 
studies, patients with first-ever depression were found to 
be at potentially increased risk (i.e. OR  1 1.4, but p  1 0.05). 
In the other 3 studies, no association was found ( table 2 ). 
Only minor differences in baseline characteristics be-
tween patients with a first-ever and a recurrent depressive 
episode that were consistent across studies could be iden-
tified: compared to patients with a recurrent depressive 
episode, patients with a first-ever depressive episode had 
lower BDI scores, they were somewhat older and less like-
ly to be smokers and to have a history of MI or diabetes.
 Post-ACS Onset versus Pre-ACS Onset Depressive 
Episodes 
 In 4 of the 6 studies cardiac outcomes were reported 
for ACS patients with post-ACS onset versus pre-ACS on-
set depression. In one of these studies patients with post-
MI onset depression were found to be at significantly in-
creased risk of worse cardiac outcomes than those with 
pre-MI onset depression. In 2 of the others, patients with 
post-ACS onset depression were found to be at potential-
ly increased risk of worse cardiac outcomes compared to 
those with pre-ACS onset depression (OR  1 1.4, p  1 0.05). 
In contrast, the fourth study found patients with pre-ACS 
onset depression to be at potentially increased risk of 
worse outcomes compared to those with post-ACS onset 
depression (OR  ! 0.7 for patients with post-ACS onset de-
pression, p  1 0.05;  table 2 ). Patients with pre-ACS onset 
depression tended to have higher BDI scores, and were 
more likely to have a history of MI and to be on antide-
pressants, but none of the other baseline characteristics 
differed consistently across studies between patients with 
pre-ACS and post-ACS onset depression.
 Incident versus Nonincident Depressive Episodes 
 Four of the 6 included studies reported outcomes for 
patients with incident versus nonincident depression. 
Two of these reported a potentially increased risk of worse 
outcomes for patients with incident depression (OR  1 1.4, 
p  1 0.05). The 2 other studies found no association be-
tween incident versus nonincident depression and car-
diac outcomes ( table  2 ). Patients with nonincident de-
pression tended to have higher BDI scores and were more 
likely to have a history of MI, but none of the other base-
line characteristics differed consistently across studies 
between patients with incident and nonincident depres-
sion.
 Quality of Studies 
 An overview of the quality of the included studies can 
be requested from the corresponding author. Out of the 
11 criteria, the number of criteria with good ratings var-
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ied between the 5 and 8 for the 6 included studies. Three 
of the studies were RCTs, whereas the other 3 were ob-
servational studies. In all studies, well-defined and ap-
propriate inclusion and exclusion criteria were used. For 
1 study it was clear that at least 70% of the eligible pa-
tients completed baseline data. For 2 studies this was 
 ! 70%, and for the 3 RCTs this was not reported because 
of the different study design. In all studies, complete fol-
low-up data were present for at least 70% of the patients 
with complete baseline data. Only 1 study provided in-
formation about nonparticipants. All, except 1, were 
multicenter studies. Two studies had  ! 25 patients with 
the outcome, 1 between 25 and 50 and 3  1 50. In 3 stud-
ies patients were recruited from a consecutive series of 
clinic admissions or appointments. In 4 studies post-
ACS depression was assessed with a clinical interview (2 
studies used the CIDI, 1 study the Depression Interview 
and Structured Hamilton and 1 study the Diagnostic In-
terview Schedule). In all studies the outcomes were as-
sessed thoroughly and reliably, and in at least 5 studies 
the outcome assessors were blind to the subgroup status. 
There was no differential loss to follow-up in any of the 
studies (loss to follow-up occurred only in 0–4% of the 
patients).
 Discussion 
 This is the first systematic review evaluating cardiac 
prognosis for subgroups of depressed ACS patients. Of 
the 14 total comparisons included in the review, only 2 
reported a statistically significant (p  ! 0.05) association 
between recurrence or onset of depression with cardio-
vascular outcomes. Because of the inconsistent findings 
from the studies reviewed, at this time no firm conclusion 
can be drawn about whether or not first-ever, post-ACS 
onset and incident depression are related to cardiac prog-
nosis.
 There are some considerations that need to be taken 
into account when interpreting these results. The first 
consideration is that the number of identified studies is 
only a small proportion of the total number of studies 
that have evaluated the impact of post-ACS depression on 
cardiac prognosis. It is not clear to what degree the set of 
identified studies is representative of all studies that have 
been conducted on post-ACS depression and cardiac 
prognosis. The second consideration is that there were 
substantial differences between the reviewed studies that 
may have resulted in the inconsistent findings. Differ-
ences in assessment of post-ACS depression may have led 
to the inclusion of different patient groups. In addition, 
within the time frame of 3 months after the acute event 
studies differed in timing of depression assessment. A 
meta-analysis  [29] found that depression assessed within 
2 weeks after the cardiac event was less strongly associ-
ated with cardiac prognosis than depression assessed lat-
er than 2 weeks after the cardiac event. In the reviewed 
studies, however, timing of depression assessment did not 
seem to have affected the results. Most studies assessed 
recurrence and timing of onset of the depressive episode 
differently, and all evaluated it retrospectively, which is 
prone to recall bias  [30] . This potentially affected the reli-
Table 2.  Odds ratios for cardiovascular outcomes for the different subgroup comparisons








Grace et al. (n = 235) 1.88 (0.95–3.71)3
De Jonge et al. (n = 72) 1.20 (0.34–4.28) 4.88 (1.01–23.55)2 2.39 (0.76–7.50)3
Parker et al. (n = 75) 1.49 (0.52–4.31)3 2.32 (0.74–7.29)3 1.49 (0.52–4.31)3
ENRICHD (n = 920)1 (1) 1.68 (1.16–2.43)2
(2) 1.51 (0.96–2.37)3
SADHART (n = 359) 0.95 (0.57–1.58) 0.69 (0.41–1.15)3 0.77 (0.42–1.42)
MIND-IT (n = 258) 0.97 (0.49–1.89) 1.54 (0.85–2.79)3 1.19 (0.69–2.04)
F igures in parentheses are 95% CI. ACS = Acute coronary syndrome; CI = confidence interval; OR = odds 
ratio.
1 Outcomes evaluated for ENRICHD were (1) all-cause mortality and (2) cardiovascular mortality (for both 
outcomes, the number of patients with the outcome assessed was n = 920).
2 Differential risk: significant at the p < 0.05 level.
3 Potential differential risk: i.e. OR > 1.40 or OR < 0.70, but not statistically significant (p > 0.05).
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ability of subgroup classification. Three studies assessed 
all-cause mortality over long follow-up periods, whereas 
the other 3 evaluated new cardiovascular events over 
shorter follow-up periods. A meta-analysis  [29] showed 
that the effect of depression on cardiac prognosis is stron-
ger when using cardiovascular mortality as an outcome 
compared to all-cause mortality, but that the length of the 
follow-up period did not matter in this association. In the 
reviewed studies the risk of worse prognosis for sub-
groups of depressed ACS patients did not seem to be af-
fected by the outcome measure or follow-up length. A 
third consideration is that 2 of the 6 studies only evalu-
ated 1 of the three subgroup comparisons  [8, 22] . The 3 
subgroup comparisons are not independent of each other 
due to the high percentage of patients classified in mul-
tiple groups (e.g. post-ACS and incident). A fourth con-
sideration is the quality of the included studies. Not all 
quality criteria were met by all studies. Three of the in-
cluded studies were RCTs on antidepressant treatment 
and 3 were prospective cohort studies. However, in all 3 
RCTs the intervention had no effect on cardiovascular 
prognosis, so the associations investigated in the present 
systematic review are not likely to be affected by the in-
tervention. Two studies had relatively small numbers of 
patients with the key outcomes, increasing the chance of 
spurious findings. Although in the reviewed studies the 
follow-up rates from baseline were very high, in at least 2 
studies  ! 70% of the eligible patients had complete base-
line data and in at least 2 of the 6 included studies patients 
were not recruited consecutively. Only 1 study provided 
information about nonparticipants, who were more like-
ly  to  be  female,  less likely to be married and on average 
7 years older than the participants  [8] . The findings from 
the included studies may therefore not apply to all ACS 
patients. A fifth consideration is that psychological dis-
tress in patients with a somatic illness is difficult to as-
sess. In order to diagnose and treat medically ill patients 
with psychological distress properly it is essential to un-
derstand many factors that go beyond DSM-IV, such as 
the patients’ life history, temperament and health-related 
behaviors  [31] . This inadequacy in diagnostic assessment 
has been suggested to be the cause of the often inconsis-
tent results in psychosomatic studies  [32] and may have 
contributed to the inconsistent findings of the studies in-
cluded in this review.
 The inconsistent findings across studies and the in-
ability to draw firm conclusions might lead to the sugges-
tion that there is little reason to continue to investigate 
the relative association of post-ACS depression subgroups 
with cardiac prognosis. Alternatively, we would argue 
that this question merits further investigation. There are 
important limitations in the existing literature in this 
area, and the question of whether subgroups of depressed 
ACS patients have worse cardiac outcomes compared to 
other subgroups is an important one. It has been argued, 
for instance, that assessments of depression among pa-
tients with heart disease may reflect worse underlying 
heart disease or comorbid conditions beyond what is ef-
fectively quantified through covariate adjustment  [33, 
34] . A better understanding of whether certain subtypes 
of post-ACS depression are qualitatively different from 
other subtypes would be helpful to understand the over-
all relationship between depression and cardiovascular 
outcomes.
 No firm consistent pattern of demographical and clin-
ical differences between subgroups was found. The minor 
differences that were found are very unlikely to underlie 
the (potentially) increased risk associated with first-ever, 
post-ACS onset and incident depression in the reviewed 
studies  [8, 9, 21, 22] . Some of the studies adjusted for con-
founding variables in the originally published reports 
and concluded that the increased risk of worse outcome 
for some subgroups was independent from these charac-
teristics. However, the number of patients in most of 
these studies was too small to effectively use multivari-
able methods. Furthermore, adjustment for confounders 
is often imprecise and incomplete. Associations found in 
studies are often confounded by unmeasured or poorly 
measured variables, and sometimes even key cardiac 
variables are, surprisingly, not found to relate to progno-
sis  [33, 35–37] . Therefore, it cannot be ruled out that the 
differential risk of worse outcome between subgroups 
found by some of the studies is caused by subgroup im-
balances in some measured or unmeasured patient char-
acteristics, such as a severer underlying coronary artery 
disease  [38, 39] or a deteriorating health status. This may 
also underlie the increased risk of worse prognosis that is 
found for cardiac patients with somatic rather than cog-
nitive symptoms of depression  [3, 40, 41] , and ACS pa-
tients with persisting or increasing depressive symptoms 
and treatment-resistant depression  [5, 6, 23, 42, 43] . MI 
patients with persisting depressive symptoms report 
worse physical health 12 months after the MI  [44] , sup-
porting that a deteriorating health status may indeed un-
derlie the association with worse prognosis. Some de-
pressed ACS patients may have ‘vascular depression’: a 
type of depression caused by vascular damage in the 
brain due to atherosclerosis  [45] . Recently, an association 
was found between depressive symptoms persisting up 
till 3 months after ACS and cerebrovascular lesions  [46] . 
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